MedPath

The Effect of Lycopene on Sperm Quality in Men Attending Fertility Clinic

Not Applicable
Active, not recruiting
Conditions
Total Motile Sperm Count
Interventions
Dietary Supplement: Lycopene
Dietary Supplement: Placebo
Registration Number
NCT05671562
Lead Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Brief Summary

The goal of this clinical trial is to test whether lycopene (an antioxidant found in cooked tomatoes) will improve the number of swimming sperm in the ejaculates of men with low total motile sperm count.

Participants will take either lycopene capsules or identical capsules containing no lycopene for 12 weeks. We will analyse the quality of their semen before and after taking the capsules, and compare the results.

Hypothesis: Supplementation with lycopene will improve testicular function (semen quality) in males with low total motile sperm count (TMSC).

Detailed Description

Impaired testicular function contributes to around 50% of heterosexual infertility and is often characterized by a low total motile sperm count. Evidence suggests that one cause of low total motile sperm count is oxidative stress within the ejaculate, where harmful oxygen species damage the sperm. Antioxidants to combat oxidative stress within the ejaculate have been proposed as a method of increasing the total motile sperm count. Lycopene is a powerful antioxidant found abundantly in cooked tomatoes and has been shown to improve testicular function in a healthy population. This double blinded randomised controlled trial aims to investigate whether lycopene can improve testicular output in participants with a low motile sperm count. Semen analysis will be carried out before and after the intervention. The intervention is a commercially available lycopene capsule or an identical placebo.

Hypothesis: Supplementation with lactolycopene will improve testicular function (semen quality) in males with low total motile sperm count (TMSC).

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Male
Target Recruitment
80
Inclusion Criteria
  1. Males aged 18 - 50 years of age
  2. Attending the Fertility Clinic at the Jessop Wing, (Sheffield Teaching Hospitals).
  3. Found to have poor testicular function as evidenced by a low motile sperm count (<20 million motile sperm per ejaculate).
  4. Willing to comply with the study procedures and provide informed consent.
Exclusion Criteria
  1. Participants who report allergy to tomatoes, whey, soy.
  2. Men with previous testicular surgery or a current or previous diagnosis of cancer.
  3. Men found to have normal sperm parameters.
  4. Known infection with hepatitis or HIV.
  5. Men with azoospermia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LycopeneLycopeneCapsules containing 7mg of lycopene. 2 capsules are swallowed once per day with water for 12 weeks. Looks identical to placebo capsule.
PlaceboPlaceboPlacebo capsules containing an inactive ingredient. 2 capsules are swallowed once per day with water for 12 weeks. Looks identical to lycopene capsule.
Primary Outcome Measures
NameTimeMethod
Total motile sperm countChange from Baseline total motile sperm count at 12 weeks

Number of swimming sperm in the total ejaculate

Secondary Outcome Measures
NameTimeMethod
Sperm motilityChange from Baseline sperm motility at 12 weeks

% of swimming sperm

Sperm DNA fragmentationChange from Baseline sperm DNA fragmentation at 12 weeks

% of sperm with fragmented DNA

Sperm concentrationChange from Baseline sperm concentration at 12 weeks

Number of sperm per ml of ejaculate

Sperm morphologyChange from Baseline sperm morphology at 12 weeks

Appearance of sperm

Oxidative reductive potential of semenChange from Baseline semen oxidative reductive potential at 12 weeks

To compare level of oxidants and antioxidants within the sample

Trial Locations

Locations (1)

Jessop Fertility

🇬🇧

Sheffield, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath